| Literature DB >> 10754315 |
U Grohmann1, J Van Snick, F Campanile, S Silla, A Giampietri, Carmine Vacca, J C Renauld, M C Fioretti, P Puccetti.
Abstract
IL-9 is a T cell-derived cytokine that, similar to the Th2 cytokines IL-4 and IL-10, has been implicated in the response to parasitic infections, allergy, and inflammatory processes. Because both IL-4 and IL-10 can confer protection to mice from septic shock, we investigated whether IL-9 may also be capable of conferring resistance on recipients of an otherwise lethal challenge with Pseudomonas aeruginosa. Prophylactic injections of rIL-9 appeared to be most effective in preventing the onset of a lethal shock, according to a pattern that was both dose dependent and time dependent. The protective effect of IL-9 was correlated with marked decreases in the production of the inflammatory mediators TNF-alpha, IL-12, and IFN-gamma, as well as the induction of the anti-inflammatory cytokine IL-10. Sustained levels of IL-9-specific transcripts could be detected in the spleens of mice recovering from sublethal P. aeruginosa infection. Therefore, IL-9 may be protective in septic shock via a rather unique mechanism involving a complex modulation of inflammatory and anti-inflammatory mediators.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10754315 DOI: 10.4049/jimmunol.164.8.4197
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422